In Japan, the standard therapy for unresectable advanced gastric cancer is S-1 and cisplatin combination chemotherapy. However, the pharmacodynamics of these agents in patients with renal dysfunction remains unclear.
We herein present a case of chronic kidney disease (CKD) in which the patient was safely given paclitaxel to treat gastric cancer with peritoneal dissemination.
Weekly paclitaxel therapy is feasible and effective for patients with advanced gastric cancer and renal impairment.